The anti-fibrotic effects of SGLT2i have been demonstrated in several CKD animal models [166,167,168,169] and in kidney tissue from patients with diabetic kidney disease receiving empagliflozin, partly due to the down-regulation of pyruvate kinase M2, the rate-limiting enzyme of glycolysis [170]
& Castorena-Gonzalez, J
Symptoms or side effects : Report any unusual symptoms, particularly severe or persistent abdominal pain, cyclical vomiting, inability to keep fluids down, reduced urine output, visual changes, or cardiovascular symptoms such as palpitations or chest discomfort
Enzyme Microb Technol 3:233242 Penninckx MJ (2000) A short review on the role of glutathione in the response of yeasts to nutritional, environmental, and oxidative stresses
A trial of six hepatocarcinoma patients on 5 g oral glutathione daily found regression or stagnation of tumor growth in three patients